4
Changes in Ownership
Prelude Therapeutics Inc Filed Acc 0001562180-22-008404
CEO bought 19,188 shares at $5.13 ($98,446)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Vaddi Krishna CEO | 2022-12-20 | Purchase | +19,188 | $5.13 | $98,446 | 120,665 | I |
| Open-market purchases · 19,188 sh · avg $5.13 · $98,446 | |||||||
Loading xslF345X03/primarydocument.xml…